Pierre A. Caudrelier
Keine laufenden Positionen mehr
Profil
Pierre A.
Caudrelier joined Theratechnologies, Inc. in 2007 and serves as Chief Medical Officer.
He served as Clinical Program Director of HIV Program for Aventis Pasteur, Vice President-Clinical Research of IDM Pharma and Vice President-Clinical Research and Chief Medical Officer of Kiadis Pharma.
Ehemalige bekannte Positionen von Pierre A. Caudrelier
| Unternehmen | Position | Ende |
|---|---|---|
CelMed BioSciences, Inc.
 CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 28.11.2006 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Aventis Pasteur Ltd. | Corporate Officer/Principal | - |
| THERATECHNOLOGIES INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Kiadis Pharma BV
 Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Pierre A. Caudrelier
| Université de Bordeaux | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERATECHNOLOGIES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CelMed BioSciences, Inc.
CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Kiadis Pharma BV operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. Its products include: ATIR101 and ATIR201. The firm’s products are based on hematopoietic blood-forming stem cell transplants from donors. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
| Aventis Pasteur Ltd. | |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |